Skip to content
All Sections
Subscribe Now
68°F
Thursday, July 18th 2024
Today's E-Edition
Home Page
Close Menu
Business
Technology
Commercial Real Estate
Housing
Marketplace
The Mercury News
SUBSCRIBE NOW
Close Menu
Morning Report in your inbox!
Sign Up
Subscribe
Account Settings
Contact Us
Log Out
Spoof a user
Morning Report in your inbox!
Sign Up
Subscribe
Search
Silicon Valley
68°F
Thursday, July 18th 2024
Today's E-Edition
Business
Technology
Commercial Real Estate
Housing
Marketplace
The Mercury News
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dynavax Technologies
(NQ:
DVAX
)
10.42
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
10.42
Bid (Size)
10.40 (5)
Ask (Size)
10.85 (3)
Prev. Close
10.42
Today's Range
10.42 - 10.42
52wk Range
10.41 - 15.15
Shares Outstanding
128,489,060
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
FDA Declines To Approve Expanded Use of Dynavax's Hepatitis B Vaccine In Hemodialysis Patients
May 14, 2024
Latest regulatory update from Dynavax on HEPLISAV-B vaccine regimen for adults on hemodialysis, with FDA's Complete Response Letter.
Via
Benzinga
Exposures
Product Safety
Dynavax Technologies (DVAX) Q1 2024 Earnings Call Transcript
May 09, 2024
DVAX earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Performance
YTD
-27.54%
-27.54%
1 Month
-7.62%
-7.62%
3 Month
-8.11%
-8.11%
6 Month
-25.41%
-25.41%
1 Year
-27.84%
-27.84%
More News
Read More
DVAX Stock Earnings: Dynavax Technologies Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
Via
InvestorPlace
Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript
February 22, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Dynavax Technologies: Q4 Earnings Insights
February 22, 2024
Via
Benzinga
Why Vera Therapeutics Stock Soared by 22% This Week
January 12, 2024
Via
The Motley Fool
Earnings Preview For Dynavax Technologies
November 01, 2023
Via
Benzinga
Preview: Dynavax Technologies's Earnings
August 02, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
May 29, 2023
Via
Benzinga
The Latest Analyst Ratings for Dynavax Technologies
May 03, 2023
Via
Benzinga
3 Stocks Set to Soar 68% to 200% Higher
January 08, 2024
Via
InvestorPlace
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
Via
Benzinga
Dynavax Technologies (DVAX) Q3 2023 Earnings Call Transcript
November 03, 2023
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Dynavax Technologies's Return On Capital Employed Insights
March 01, 2023
Via
Benzinga
Cramer Suggests Buying Fast Food Chain Owner Of Popeye's, Burger King: Here's Why
September 07, 2023
Via
Benzinga
Dynavax Technologies Stock Sees Renewed Technical Strength
August 07, 2023
Via
Investor's Business Daily
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
August 04, 2023
Via
Benzinga
Dynavax Technologies (DVAX) Q2 2023 Earnings Call Transcript
August 04, 2023
Via
The Motley Fool
Overview Of Value Stocks In The Healthcare Sector
July 31, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
July 24, 2023
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
July 17, 2023
Via
Benzinga
The 7 Best Stocks Under $15 to Buy in June 2023
June 01, 2023
Via
InvestorPlace
Dynavax Technologies (DVAX) Q1 2023 Earnings Call Transcript
May 02, 2023
Via
The Motley Fool
7 Biotech Stocks Sitting in the Sweet Spot
March 24, 2023
Via
InvestorPlace
The Top 7 Growth Stocks in Biotech
March 03, 2023
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close